Price $1.75 |
Market Cap
134.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.83
|
P/S
46.39
|
Dividend %
-
|
|
P/CF
23.7
|
P/FCF
-
|
Op. Cash Flow
-29.5K
|
FCF
-0.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-76.80%
|
ROI
-70.30%
|
|
ROA
-58.90%
|
EPS Growth
27.80%
|
Current Ratio
5.6
|
Debt/Equity
13.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Opiant Pharmaceuticals Inc (OPNT) | $14.86 | - | - | 44.2M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $23.99 | - | 3.90% | 22.05B | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.25 | - | 4.40% | 172.5M | Strong Buy |
| Mannatech, Inc. (MTEX) | $20.40 | - | 2.40% | 57.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
